about
Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-cau...
Read More
9.48
-0.39
(-3.95%)
449.7K
XNAS Volume
XNAS 14 May, 2026 1:53 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Arvinas Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..